Company page
Promis Neurosciences Inc.
Promis Neurosciences Inc. is a public company traded under the ticker PMN in the American market. The company has a market capitalization of approximately $22.7 million. Promis focuses on developing innovative therapies for neurodegenerative diseases.
- Ticker
- PMN:NASDAQ
- Asset type
- Stock
- Market cap
- $22.7M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD